January 30, 2019
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma
Read More
January 30, 2019
Study in Patients With Advanced Soft Tissue Sarcoma (STS) After Failure of Anthracyclines and/or Ifosfamide
Read More
January 30, 2019
Occipital Nerve Stimulation in Medically Intractable Chronic Cluster Headache
Read More
January 30, 2019
A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)
Read More
January 30, 2019
A Study Comparing the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Chronic Cluster Headache (CCH)
Read More
January 30, 2019
Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
Read More
January 30, 2019
Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Read More
January 30, 2019
Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
Read More
January 30, 2019
Nintedanib(BIBF1120) in Thyroid Cancer
Read More
January 30, 2019
Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
Read More
January 30, 2019
A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis
Read More
January 30, 2019
Safety and Efficacy of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
Read More
Load More
X